| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |